New hope for rare cancers left behind by modern medicine
NCT ID NCT06790706
Summary
This French study is testing whether a combination of two immunotherapy drugs can help control five types of advanced rare cancers that have progressed after standard treatment. It will enroll 154 adults whose cancers have specific rare origins, such as certain mesotheliomas, thyroid cancers, and neuroendocrine tumors. The main goal is to see if the drug combination can stop the cancer from growing for at least 24 weeks, offering a new option where few exist.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AP-HM, TIMONE Hospital, medical oncology department
NOT_YET_RECRUITINGMarseille, 13009, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
AP-HP, Tenon Hospital, medical oncology department
NOT_YET_RECRUITINGParis, 75020, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Eugène Marquis, medical oncology department
NOT_YET_RECRUITINGRennes, 35042, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Hospitalier Universitaire de Lille, medical oncology department
NOT_YET_RECRUITINGLille, 59037, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hospices Civils de Lyon, Medical Oncology Department, Edouard Herriot Hospital
RECRUITINGLyon, 69003, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hospices Civils de Lyon, Medical Oncology Department, Lyon SUD Hospital
RECRUITINGPierre-Bénite, 69310, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hospices Civils de Lyon, Thoracic Oncology Department, Louis Pradel Hospital
RECRUITINGBron, 69500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Insitut de Cancérologie Strasbourg Europe, medical oncology department
NOT_YET_RECRUITINGStrasbourg, 67200, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut Bergonié, medical oncology department
NOT_YET_RECRUITINGBordeaux, 33076, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut Curie, thoracic oncology department
NOT_YET_RECRUITINGParis, 75005, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut Gustave Roussy, medical oncology department
NOT_YET_RECRUITINGVillejuif, 94805, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut Paoli-Calmettes Marseille, medical oncology department
NOT_YET_RECRUITINGMarseille, 13009, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut Régional du Cancer de Montpellier, medical oncology department
NOT_YET_RECRUITINGMontpellier, 34298, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut de Cancerologie de l'Ouest , medical oncology department
NOT_YET_RECRUITINGAngers, 49055, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
ONCOPOLE Claudius Regaud, IUCT-Oncopole, medical oncology department
NOT_YET_RECRUITINGToulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.